News / Business
POZEN Inc (NASDAQ:POZN) to Present at Jefferies & Co. Annual Healthcare Conference June 24
POZEN, Inc (NASDAQ:POZN) will speak at the Jeffereies & Co Annual Healthcare Conference on Tuesday, June 24 at 8:00 am ET in
POZEN Inc. (POZEN) is a pharmaceutical company focused on developing products, which can provide improved efficacy, safety or patient convenience in the treatment of acute and chronic pain, and pain related conditions.
The Company has developed Treximet (formerly known as Trexima) in collaboration with GlaxoSmithKline (GSK). Treximet is the proposed brand name for the product candidate combining sumatriptan 85 milligram, as the succinate salt, formulated with RT Technology and naproxen sodium 500 milligram in a single tablet designed for the acute treatment of migraine.
The United States Food and Drug Administration (FDA) has notified POZEN that it has tentatively accepted the trade name Treximet, subject to final approval of the new drug application (NDA) for the product. Treximet incorporates the Company’s MT 400 technology, which refers to its combinations of a triptan (5-HT1B/1D agonist) and a non-steroidal, anti-inflammatory drug (NSAID).
Find more Conference Calls or post your own events on YourFindit Events at:
http://events.yourfindit.com/Events_List.aspx?catid=12
Join the brand-new business networking community site, YourFindit, and create your profile.
